Abstract
Background: Studies showed that bowel rehabilitation therapy, including recombinant human growth hormone (rhGH), nutrition support, glutamine, and dietary fiber, promotes intestinal adaptation in patients with short bowel syndrome. The aim of the current study was to determine if enteral nutrition and rhGH are effective in weaning short bowel patients off total parenteral nutrition (TPN). Methods: Thirty-seven patients with short bowel syndrome received bowel rehabilitation therapy for 4 weeks. Thirty-four patients were treated within 2 years after short bowel syndrome. Treatment included nutrition support from enteral nutrition 500 to 1500 kcal/d, oral glutamine 0.6 g/kg/d, plus a high-carbohydrate and low-fat diet. Once patients were in positive nitrogen balance, rhGH 0.05 mg/kg/d was administered for 3 weeks. Results: All patients completed the treatment; there were no deaths caused by malnutrition. Intestinal absorptive capacity and plasma levels of proteins were significantly improved after treatment (p< .05). Of the 23 patients who have been followed for >2 years after bowel rehabilitation therapy, 21 patients (57%) weaned off parenteral nutrition, among which 18 (49%) patients lived on a high-carbohydrate and low-fat diet supplemented with enteral nutrition, and 3 patients were free of enteral nutrition and relied on high-carbohydrate and low-fat diet alone. The minimal intestinal length for these patients was 15 cm with ileocecal valve and intact colon in adults. Conclusions: Providing patients with enteral nutrition, glutamine, dietary fiber, and rhGH during bowel rehabilitation therapy allows weaning from TPN in a significant number of patients.
Thirty-seven patients with short bowel syndrome received bowel rehabilitation therapy with enteral nutrition supplemented with high carbohydrate low fat diet (HCLF diet), glutamine and recombinant human growth hormone, after which 21 patients weaned off total parenteral nutrition and relied on enteral nutrition and HCLF diet. These results suggest that providing patients with enteral nutrition and HCLF diet, glutamine, and recombinant human growth hormone may allow weaning off parenteral nutrition in a significant number of patients.
Get full access to this article
View all access options for this article.
